N@N

Cord Blood America: Cord Blood America Top Stock Performer in ETF Innovators Global Stem Cell and Regenerative Medicine Index

^{Published on 2009-03-05 07:09:41, Last Modified on 2009-11-04 08:10:56 - Market Wire}
 

SANTA MONICA, CA--(Marketwire - March 5, 2009) - On the day that President Obama's [ White House Health Care Summit ] commenced, Cord Blood America, Inc. (OTCBB: [ CBAI ]), the umbilical [ cord blood ][ stem cell ] preservation company ([ http://www.cordblood-america.com ]) focused on bringing the life saving potential of [ stem cells ] to families nationwide and internationally, reported that the Company, now listed on the ETF Innovators Emerging Stem Cell Index of U.S.-listed stocks, is the top stock price gainer year-to-date, up 279.2 percent. For more information, see Cord Blood America's Social Media News Room and Blogs at [ Intelligendo.com ].

The analysis is available at:[ http://www.biomedreports.com/articles/most-popular/594-analysis-of-stem-cell-index-ytd.html ]

The table includes statistics for the 40 companies in the [ ETF Innovators ][ Global Stem Cell and Regenerative Medicine Index ]. Cord Blood America recently announced a successful debt restructuring and projected cash flow positive financial results. ETF Innovators is noted for creating new global equity indexes with a focus in the healthcare industry. ETF Innovators tracks the total market value and stock price changes as an indicator of investor and trader sentiment toward the stem cell and [ regenerative medicine ] space.

"We are pleased by these results and the market's reaction to our strategy. We will maintain the focus of strategic organic growth, accretive acquisitions and de-levering the balance sheet in 2009. We strongly believe also that the [ Obama ] Administration will soon lift restrictions on Federal funding for [ stem cell research ], which really should spark interest in the sector," said Matthew Schissler, Founder and CEO.

About Cord Blood America

Cord Blood America (OTCBB: [ CBAI ]) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTCBB: [ CBAI ]), visit our website at[ www.corcell.com ]. For investor information, visit [ www.cordblood-america.com ].